IL18 and COVID-19: Levels were most pronounced in samples taken at early time points post onset of COVID-19 symptoms with the exception of TNF-α and IL-18 which remained high in all hospitalised patients or even increased (IL-18) in samples taken at day 21-30 post symptoms (Figure 4).